Success Metrics

Clinical Success Rate
92.5%

Based on 62 completed trials

Completion Rate
93%(62/67)
Active Trials
16(15%)
Results Posted
29%(18 trials)
Terminated
5(5%)

Phase Distribution

Ph phase_2
20
19%
Ph phase_3
9
9%
Ph not_applicable
59
56%
Ph early_phase_1
2
2%
Ph phase_1
12
11%

Phase Distribution

14

Early Stage

20

Mid Stage

9

Late Stage

Phase Distribution102 total trials
Early Phase 1First-in-human
2(2.0%)
Phase 1Safety & dosage
12(11.8%)
Phase 2Efficacy & side effects
20(19.6%)
Phase 3Large-scale testing
9(8.8%)
N/ANon-phased studies
59(57.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

84.9%

62 of 73 finished

Non-Completion Rate

15.1%

11 ended early

Currently Active

16

trials recruiting

Total Trials

105

all time

Status Distribution
Active(24)
Completed(62)
Terminated(11)
Other(8)

Detailed Status

Completed62
Recruiting13
unknown8
Not yet recruiting7
Withdrawn6
Terminated5

Development Timeline

Analytics

Development Status

Total Trials
105
Active
16
Success Rate
92.5%
Most Advanced
Phase 3

Trials by Phase

Early Phase 12 (2.0%)
Phase 112 (11.8%)
Phase 220 (19.6%)
Phase 39 (8.8%)
N/A59 (57.8%)

Trials by Status

recruiting1312%
completed6259%
unknown88%
not_yet_recruiting77%
terminated55%
withdrawn66%
enrolling_by_invitation11%
active_not_recruiting33%

Recent Activity

Clinical Trials (105)

Showing 20 of 105 trialsScroll for more
NCT05040711Not Applicable

mHealth Mindfulness With Patients With Serious Illness and Their Caregivers

Recruiting
NCT06832670Not Applicable

Nursing Strategies to Increase Vaccination Rates in Adolescents: Education, Video Animation and Games

Completed
NCT07075588Not Applicable

Integrating Free-choice Marketplace, dieTitian coacHing, cultuRally Tailored messagIng to improVE Blood Pressure

Not Yet Recruiting
NCT04781387Phase 2

Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection

Completed
NCT06671483Phase 3

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

Recruiting
NCT06868290Phase 2

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA

Recruiting
NCT07419763Not Applicable

Intra Oral Appliance (IOA) Model Evaluating the Efficacy of Sensitive Toothpaste

Completed
NCT07419685Not Applicable

Intraoral Appliance (IOA) Model Evaluating the Efficacy of a Whitening Toothpaste

Completed
NCT07317284Not Applicable

Evaluation and Treatment for Diabetic Peripheral Neuropathy

Completed
NCT05247255Early Phase 1

Quadratus Lumborum Block for Total Hip Arthroplasty

Recruiting
NCT07300358Not Applicable

Study on the Safety and Effectiveness of a Biodegradable Patent Foramen Ovale Occluder System

Not Yet Recruiting
NCT06126757Not Applicable

PelviSense, an Innovative, Non-invasive, Biofeedback Device for the Treatment of Stress Urinary Incontinence in Women

Active Not Recruiting
NCT06257550Not Applicable

AdapTive Personalized Dietitian coacHing, Messaging and pRoduce prescrIption to improVE Healthy Dietary Behaviors

Completed
NCT04519645Phase 2

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures

Terminated
NCT04553705Phase 2

Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19)

Completed
NCT07188545

Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)

Active Not Recruiting
NCT07168226Phase 2

Phase 2 Cachexia Clinical Trial to Evaluate the Efficacy and Safety of ASCA101

Not Yet Recruiting
NCT04510597Phase 3

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Recruiting
NCT05359926Not Applicable

Early Versus Delayed Urinary Catheter Removal After Minimally Invasive Lumbar Spine Surgery

Withdrawn
NCT06526052Not Applicable

A Randomized Controlled Trial Testing the Effect of the Youth Mindful Awareness Program on Negative Affect (YMAP2).

Recruiting

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
105